Aravintakshan S A

IV
4papers
16citations
Novelty46%
AI Score25

4 Papers

CVJul 16, 2024
A Channel Attention-Driven Hybrid CNN Framework for Paddy Leaf Disease Detection

Pandiyaraju V, Shravan Venkatraman, Abeshek A et al.

Farmers face various challenges when it comes to identifying diseases in rice leaves during their early stages of growth, which is a major reason for poor produce. Therefore, early and accurate disease identification is important in agriculture to avoid crop loss and improve cultivation. In this research, we propose a novel hybrid deep learning (DL) classifier designed by extending the Squeeze-and-Excitation network architecture with a channel attention mechanism and the Swish ReLU activation function. The channel attention mechanism in our proposed model identifies the most important feature channels required for classification during feature extraction and selection. The dying ReLU problem is mitigated by utilizing the Swish ReLU activation function, and the Squeeze-andExcitation blocks improve information propagation and cross-channel interaction. Upon evaluation, our model achieved a high F1-score of 99.76% and an accuracy of 99.74%, surpassing the performance of existing models. These outcomes demonstrate the potential of state-of-the-art DL techniques in agriculture, contributing to the advancement of more efficient and reliable disease detection systems.

IVJul 15, 2024
Leveraging Bi-Focal Perspectives and Granular Feature Integration for Accurate Reliable Early Alzheimer's Detection

Shravan Venkatraman, Pandiyaraju V, Abeshek A et al.

Being the most commonly known neurodegeneration, Alzheimer's Disease (AD) is annually diagnosed in millions of patients. The present medical scenario still finds the exact diagnosis and classification of AD through neuroimaging data as a challenging task. Traditional CNNs can extract a good amount of low-level information in an image while failing to extract high-level minuscule particles, which is a significant challenge in detecting AD from MRI scans. To overcome this, we propose a novel Granular Feature Integration method to combine information extraction at different scales along with an efficient information flow, enabling the model to capture both broad and fine-grained features simultaneously. We also propose a Bi-Focal Perspective mechanism to highlight the subtle neurofibrillary tangles and amyloid plaques in the MRI scans, ensuring that critical pathological markers are accurately identified. Our model achieved an F1-Score of 99.31%, precision of 99.24%, and recall of 99.51%. These scores prove that our model is significantly better than the state-of-the-art (SOTA) CNNs in existence.

IVSep 25, 2024
Targeted Neural Architectures in Multi-Objective Frameworks for Complete Glioma Characterization from Multimodal MRI

Shravan Venkatraman, Pandiyaraju V, Abeshek A et al.

Brain tumors result from abnormal cell growth in brain tissue. If undiagnosed, they cause neurological deficits, including cognitive impairment, motor dysfunction, and sensory loss. As tumors grow, intracranial pressure increases, potentially leading to fatal complications such as brain herniation. Early diagnosis and treatment are crucial to controlling these effects and slowing tumor progression. Deep learning (DL) and artificial intelligence (AI) are increasingly used to assist doctors in early diagnosis through magnetic resonance imaging (MRI) scans. Our research proposes targeted neural architectures within multi-objective frameworks that can localize, segment, and classify the grade of these gliomas from multimodal MRI images to solve this critical issue. Our localization framework utilizes a targeted architecture that enhances the LinkNet framework with an encoder inspired by VGG19 for better multimodal feature extraction from the tumor along with spatial and graph attention mechanisms that sharpen feature focus and inter-feature relationships. For the segmentation objective, we deployed a specialized framework using the SeResNet101 CNN model as the encoder backbone integrated into the LinkNet architecture, achieving an IoU Score of 96%. The classification objective is addressed through a distinct framework implemented by combining the SeResNet152 feature extractor with Adaptive Boosting classifier, reaching an accuracy of 98.53%. Our multi-objective approach with targeted neural architectures demonstrated promising results for complete glioma characterization, with the potential to advance medical AI by enabling early diagnosis and providing more accurate treatment options for patients.

IVSep 1, 2024
Leveraging SeNet and ResNet Synergy within an Encoder-Decoder Architecture for Glioma Detection

Pandiyaraju V, Shravan Venkatraman, Abeshek A et al.

Brain tumors are abnormalities that can severely impact a patient's health, leading to life-threatening conditions such as cancer. These can result in various debilitating effects, including neurological issues, cognitive impairment, motor and sensory deficits, as well as emotional and behavioral changes. These symptoms significantly affect a patient's quality of life, making early diagnosis and timely treatment essential to prevent further deterioration. However, accurately segmenting the tumor region from medical images, particularly MRI scans, is a challenging and time-consuming task that requires the expertise of radiologists. Manual segmentation can also be prone to human errors. To address these challenges, this research leverages the synergy of SeNet and ResNet architectures within an encoder-decoder framework, designed specifically for glioma detection and segmentation. The proposed model incorporates the power of SeResNet-152 as the backbone, integrated into a robust encoder-decoder structure to enhance feature extraction and improve segmentation accuracy. This novel approach significantly reduces the dependency on manual tasks and improves the precision of tumor identification. Evaluation of the model demonstrates strong performance, achieving 87% in Dice Coefficient, 89.12% in accuracy, 88% in IoU score, and 82% in mean IoU score, showcasing its effectiveness in tackling the complex problem of brain tumor segmentation.